~~<i id='ED958EDF7D'><strike id='ED958EDF7D'><tt id='ED958EDF7D'><pre id='ED958EDF7D'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：explore 2025-09-29 09:07:48 Page View：7

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What a koala virus tells us about the human genome
Next article： Peter Hotez and the public health issue of online harassment

Wikipedia

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Ripples from Flovent's discontinuation is killing children with asthma

GettyImagesAspediatricianswhotakecareofchildrenintheinpatient,emergency,andprimarycaresettings,weare

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

STAT Summit: Ending the crisis of Black deaths in the U.S.

MonicaMcLemore,aprofessorandinterimassociatedeanforequity,diversity,andinclusionattheUniversityofWas